Adult-Onset Still's Disease: A Case Report and Review of Current Therapeutic Options

被引:2
作者
Thomas, Steffi [1 ]
Kesarwani, Vartika [2 ]
Graber, Melanie [3 ]
Joshi, Weishali [4 ]
机构
[1] Univ Connecticut, Dept Rheumatol, Farmington, CT USA
[2] Univ Connecticut, Dept Internal Med, Farmington, CT 06030 USA
[3] Univ Connecticut Hlth, Dept Rheumatol, Farmington, CT USA
[4] St Francis Hosp & Med Ctr, Dept Rheumatol, Hartford, CT USA
关键词
treatment; still's disease; interleukin-6; inhibitors; tocilizumab; adult-onset still's disease; BIOLOGIC AGENTS; SERUM FERRITIN; MULTICENTER; CLASSIFICATION; TOCILIZUMAB; ARTHRITIS; EFFICACY; ANAKINRA; CRITERIA;
D O I
10.7759/cureus.22743
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adult-onset Still's disease (AOSD) is a rare autoinflammatory disease that typically presents with a triad of fever, evanescent rash, and arthritis. There is often a delay in diagnosis of AOSD due to its nonspecific clinical presentation, which may mimic other infectious, rheumatological disorders, and malignancies. Corticosteroids have been the cornerstone for the management of AOSD for the past many years. However, with the expanding understanding of its pathogenesis, novel therapeutic options targeting various cytokines are being increasingly recognized. Herein, we present a case of AOSD that was successfully treated with tocilizumab, a monoclonal antibody against the interleukin-6 (IL-6) receptor. For the purpose of this article, we also conducted a literature search to review the current therapeutic options available for the treatment of AOSD.
引用
收藏
页数:6
相关论文
共 42 条
[1]  
Akritidis N, 1996, J RHEUMATOL, V23, P201
[2]   Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study [J].
Brunner, Hermine, I ;
Quartier, Pierre ;
Alexeeva, Ekaterina ;
Constantin, Tamas ;
Kone-Paut, Isabelle ;
Marzan, Katherine ;
Schneider, Rayfel ;
Wulffraat, Nico M. ;
Chasnyk, Vyacheslav ;
Tirosh, Irit ;
Kallinich, Tilmann ;
Kuemmerle-Deschner, Jasmin ;
Wouters, Carine ;
Lauwerys, Bernard ;
Nikishina, Irina ;
Trachana, Maria ;
Vougiouka, Olga ;
Martini, Alberto ;
Lovell, Daniel J. ;
Levy, Jeremy ;
Vritzali, Eleni ;
Ruperto, Nicolino .
ARTHRITIS & RHEUMATOLOGY, 2020, 72 (12) :2147-2158
[3]   STILL,S DISEASE IN ADULT [J].
BYWATERS, EG .
ANNALS OF THE RHEUMATIC DISEASES, 1971, 30 (02) :121-+
[4]  
Caramaschi P, 2002, CLIN EXP RHEUMATOL, V20, P113
[5]   Adult-onset Still's disease: Advances in the treatment [J].
Castaneda, Santos ;
Blanco, Ricardo ;
Gonzalez-Gay, Miguel A. .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2016, 30 (02) :222-238
[6]   Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts [J].
Colafrancesco, Serena ;
Manara, Maria ;
Bortoluzzi, Alessandra ;
Serban, Teodora ;
Bianchi, Gerolamo ;
Cantarini, Luca ;
Ciccia, Francesco ;
Dagna, Lorenzo ;
Govoni, Marcello ;
Montecucco, Carlomaurizio ;
Priori, Roberta ;
Ravelli, Angelo ;
Sfriso, Paolo ;
Sinigaglia, Luigi .
ARTHRITIS RESEARCH & THERAPY, 2019, 21 (01)
[7]   ADULT-ONSET STILLS DISEASE - CLINICAL COURSE AND OUTCOME [J].
CUSH, JJ ;
MEDSGER, TA ;
CHRISTY, WC ;
HERBERT, DC ;
COOPERSTEIN, LA .
ARTHRITIS AND RHEUMATISM, 1987, 30 (02) :186-194
[8]   Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence [J].
de Boysson, Hubert ;
Fevrier, Jerome ;
Nicolle, Amelie ;
Auzary, Christophe ;
Geffray, Loik .
CLINICAL RHEUMATOLOGY, 2013, 32 (01) :141-147
[9]   Tumour necrosis factor a blocking agents in refractory adult Still's disease: an observational study of 20 cases [J].
Fautrel, B ;
Sibilia, J ;
Mariette, X ;
Combe, B .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) :262-266
[10]   Proposal for a new set of classification criteria for adult-onset Still disease [J].
Fautrel, B ;
Zing, E ;
Golmard, JL ;
Le Moel, G ;
Bissery, A ;
Rioux, C ;
Rozenberg, S ;
Piette, JC ;
Bourgeois, P .
MEDICINE, 2002, 81 (03) :194-200